NuvOx Therapeutics, Inc.

CIK 1966126 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NuvOx Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 17, 2026S-10001213900-26-079095
Nov 22, 2024D0001213900-24-101639
Feb 15, 2023D0001966126-23-000001